tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Vericel price target lowered to $58 from $61 at Canaccord

Canaccord lowered the firm’s price target on Vericel (VCEL) to $58 from $61 and keeps a Buy rating on the shares. The firm said they posted a solid quarter, beating bottom-line metrics but slightly missing MACI expectations while Epicel generated lower revenue than anticipated, even with the highest number of Epicel biopsies in a Q since 2023.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1